Claudia Dallinger

749 total citations
10 papers, 582 citations indexed

About

Claudia Dallinger is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claudia Dallinger has authored 10 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claudia Dallinger's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Renal cell carcinoma treatment (2 papers). Claudia Dallinger is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Renal cell carcinoma treatment (2 papers). Claudia Dallinger collaborates with scholars based in Germany, United Kingdom and Austria. Claudia Dallinger's co-authors include R. Kaiser, Rozsa Schlenker‐Herceg, Kristell Marzin, Gerald J. Roth, Florian Colbatzky, Frank Hilberg, Rudolf Binder, Ulrike Schmid, Matthias Freiwald and Peter Stopfer and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Clinical Pharmacokinetics.

In The Last Decade

Claudia Dallinger

10 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Dallinger Germany	8	326	156	115	96	75	10	582
Kristell Marzin Germany	11	312 1.0×	169 1.1×	196 1.7×	55 0.6×	47 0.6×	18	545
Youwei Bi United States	14	307 0.9×	225 1.4×	275 2.4×	32 0.3×	55 0.7×	25	768
Patrick Cohen France	12	141 0.4×	135 0.9×	209 1.8×	49 0.5×	26 0.3×	26	556
Giuseppe Viscardi Italy	15	264 0.8×	288 1.8×	400 3.5×	37 0.4×	49 0.7×	46	871
Masahiko Ikeda Japan	15	114 0.3×	218 1.4×	297 2.6×	77 0.8×	156 2.1×	55	655
Chris Tsopelas Australia	16	122 0.4×	136 0.9×	168 1.5×	70 0.7×	76 1.0×	51	651
Midori Ando Japan	11	62 0.2×	133 0.9×	85 0.7×	69 0.7×	79 1.1×	22	422
Sandeep Batra United States	10	64 0.2×	274 1.8×	134 1.2×	113 1.2×	24 0.3×	38	689
Yutaka Nakajima Japan	13	41 0.1×	117 0.8×	98 0.9×	90 0.9×	22 0.3×	34	437
Simonetta Andrea Licandro Italy	11	131 0.4×	186 1.2×	120 1.0×	30 0.3×	43 0.6×	22	462

Countries citing papers authored by Claudia Dallinger

Since Specialization

Citations

This map shows the geographic impact of Claudia Dallinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Dallinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Dallinger more than expected).

Fields of papers citing papers by Claudia Dallinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Dallinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Dallinger. The network helps show where Claudia Dallinger may publish in the future.

Co-authorship network of co-authors of Claudia Dallinger

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Dallinger. A scholar is included among the top collaborators of Claudia Dallinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Dallinger. Claudia Dallinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wind, Sven, Ulrike Schmid, Matthias Freiwald, et al.. (2019). Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. Clinical Pharmacokinetics. 58(9). 1131–1147. 138 indexed citations

Marzin, Kristell, et al.. (2018). Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 43(5). 533–541. 29 indexed citations

Schmid, Ulrike, et al.. (2017). Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis. Cancer Chemotherapy and Pharmacology. 81(1). 89–101. 17 indexed citations

Schmid, Ulrike, et al.. (2017). Population pharmacokinetics of nintedanib in patients with idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 48. 136–143. 21 indexed citations

Marzin, Kristell, Gunther Kretschmar, Rozsa Schlenker‐Herceg, et al.. (2017). Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment. The Journal of Clinical Pharmacology. 58(3). 357–363. 22 indexed citations

Schmid, Ulrike, Benjamin Weber, Claudia Dallinger, et al.. (2016). Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis. OA4963–OA4963. 2 indexed citations

Dallinger, Claudia, Dirk Trommeshauser, Kristell Marzin, et al.. (2016). Pharmacokinetic Properties of Nintedanib in Healthy Volunteers and Patients With Advanced Cancer. The Journal of Clinical Pharmacology. 56(11). 1387–1394. 45 indexed citations

Roth, Gerald J., Rudolf Binder, Florian Colbatzky, et al.. (2014). Nintedanib: From Discovery to the Clinic. Journal of Medicinal Chemistry. 58(3). 1053–1063. 259 indexed citations

Eisen, Tim, Yaroslav Shparyk, Nicholas MacLeod, et al.. (2013). Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study. Investigational New Drugs. 31(5). 1283–1293. 48 indexed citations

10.

Eisen, Tim, Yaroslav Shparyk, Nicholas MacLeod, et al.. (2012). Effects of nintedanib (BIBF 1120) on QTc interval in previously untreated patients with renal cell cancer (RCC): Results from an open-label, phase II study.. Journal of Clinical Oncology. 30(15_suppl). e15037–e15037. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact